February 2010 - Volume 29 - Issue 2
pp: A7-A8,95-192,e11-e25


Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine

Block, Stan L.; Brown, Darron R.; Chatterjee, Archana; More

Pediatric Infectious Disease Journal. 29(2):95-101, February 2010.

Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants: A Randomized Double-Blind Placebo-Controlled Study

Englund, Janet A.; Walter, Emmanuel; Black, Steven; More

Pediatric Infectious Disease Journal. 29(2):105-110, February 2010.

  • Press Release

Group B Streptococcus Early-Onset Disease in Emilia-Romagna: Review After Introduction of a Screening-Based Approach

Berardi, Alberto; Lugli, Licia; Baronciani, Dante; More

Pediatric Infectious Disease Journal. 29(2):115-121, February 2010.

Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux

Dias, Cristiane S.; Silva, Jose Maria P.; Diniz, Jose Silverio S.; More

Pediatric Infectious Disease Journal. 29(2):139-144, February 2010.

A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months

Díez-Domingo, Javier; Cantarino, M Victoria Planelles; Torrentí, Jose M. Baldó; More

Pediatric Infectious Disease Journal. 29(2):148-152, February 2010.









Original Studies


Burden of Childhood Rotavirus Disease on Health Systems in the United States: Results From Active Surveillance Before Rotavirus Vaccine Introduction

Mast, T Christopher; Walter, Emmanuel B.; Bulotsky, Monique; More

Pediatric Infectious Disease Journal. 29(2):e19-e25, February 2010.

1 2 3 4 5